Hypertension is a major modifiable risk factor for cardiovascular disease. The current treatment strategy for treating hypertension in older adults has evolved through a series of randomised control trials over the past three decades. Beneficial effects of treating hypertension up to the age of 80 years has been unequivocally established while the benefits of treating it beyond that age need to be weighed against the risks involved in this vulnerable group of adults.